EuroTIDES 2005--Sixth Annual IBC Conference. Oligonucleotide, RNAi and peptides for the drug development and manufacturing industry.
Corey
David R
DR
University of Texas Southwestern Medical Center, Department of Pharmacology and Biochemistry, 5323 Harry Hines Boulevard, TX 75390, USA. david.corey@utsouthwestern.edu
D000818:Animals; D002986:Clinical Trials as Topic; D015195:Drug Design; D004345:Drug Industry; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D008081:Liposomes; D016376:Oligonucleotides, Antisense / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D010455:Peptides / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D019098:Telomerase / Q000037:antagonists & inhibitors; D051217:Toll-Like Receptor 9 / Q000819:agonists
D008081:Liposomes; D016376:Oligonucleotides, Antisense; D010455:Peptides; D034741:RNA, Small Interfering; D051217:Toll-Like Receptor 9; D019098:Telomerase